Max Robotics — Global Service Robot Directory + US Certification

About

Dr. Hiroyuki Shikuma is a pioneering urologic surgeon whose work is reshaping the landscape of robotic surgery, particularly in oncology. His primary research focuses on the clinical application and optimization of robotic systems—including the novel hinotori™ Surgical Robot System—for complex procedures such as robot-assisted radical prostatectomy (RARP), partial nephrectomy, and adrenalectomy. Dr. Shikuma’s major contributions lie in rigorously evaluating surgical outcomes and patient quality of life. His 2024 study on the hinotori™ system (8 citations) provided critical real-world evidence of its safety and effectiveness for urologic tumors, marking a significant step in surgical innovation. Furthermore, his propensity-matched analyses have identified key predictors of postoperative urinary incontinence and sexual function, offering surgeons actionable insights to preserve patient well-being. Notably, his work on preoperative serum testosterone levels as a predictor of preserved sexual function after nerve-sparing RARP (3 citations) has opened new avenues for personalized surgical counseling. With multiple high-impact studies from 2024-2025, Dr. Shikuma is establishing himself as a leading voice in evidence-based robotic urology, directly improving surgical precision and long-term patient outcomes.